160 results
Page 5 of 8
6-K
EX-99.1
wy2 5swoc
15 Oct 20
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
5:27pm
S-8
EX-4.1
yltsc9ui
9 Oct 20
Registration of securities for employees
4:32pm
S-8
EX-99.1
4g8iv0mkynvid7pwp
9 Oct 20
Registration of securities for employees
4:32pm
6-K
EX-99.1
ri25f1rkjg2 8xix
25 Sep 20
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
6:05am
6-K
EX-99.1
ru1tg4nx
11 Sep 20
Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients
6:05am
6-K
EX-99.1
548ahdoebbthwfnoruf
19 Aug 20
Current report (foreign)
6:00am
6-K
EX-99.2
0bdfn4ght7oq
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.2
zb9wlfcv qyi
11 May 20
Current report (foreign)
4:05pm
6-K
3u8c9msqcuulu
29 Apr 20
Current report (foreign)
4:39pm
6-K
EX-99.1
ant9y3o4f24obvlp
16 Apr 20
Galapagos and Ryvu announce research collaboration
6:05am
6-K
EX-99.2
dlz90u2l5gk90
27 Mar 20
Publication of the annual report and invitation to the The annual report for the financial year 2019, including a review of figures and performance, is available online at
4:49pm
6-K
EX-99.3
xtogjn
27 Mar 20
Publication of the annual report and invitation to the The annual report for the financial year 2019, including a review of figures and performance, is available online at
4:49pm
6-K
EX-99.10
m9z6b0c
27 Mar 20
Publication of the annual report and invitation to the The annual report for the financial year 2019, including a review of figures and performance, is available online at
4:49pm